Roger Dansey
Director/Board Member bei INOVIO PHARMACEUTICALS, INC.
Vermögen: 49 732 $ am 31.03.2024
Profil
Gegenwärtig bekleidet Roger D. Dansey die Position des Chief Medical Officer bei Seagen Inc. In der Vergangenheit hatte Dr. Dansey die Position des Vice President-Oncology Clinical Research bei Gilead Sciences, Inc. und SVP & Head-Therapeutic Area bei Merck Research Laboratories Massachusetts LLC inne. Dr. Dansey hat an der University of the Witwatersrand promoviert.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
16.11.2023 | 3 583 ( 0,02% ) | 49 732 $ | 31.03.2024 |
Aktive Positionen von Roger Dansey
Unternehmen | Position | Beginn |
---|---|---|
INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 13.05.2021 |
KRONOS BIO, INC. | Director/Board Member | 20.04.2023 |
Ehemalige bekannte Positionen von Roger Dansey
Unternehmen | Position | Ende |
---|---|---|
SEAGEN INC. | Chief Executive Officer | 09.11.2022 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | 01.04.2018 |
MERCK & CO., INC. | Corporate Officer/Principal | 01.04.2018 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.01.2014 |
Ausbildung von Roger Dansey
University of the Witwatersrand | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
INOVIO PHARMACEUTICALS, INC. | Health Technology |
KRONOS BIO, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |